<p>Immunotherapy in multiple myeloma first investigated with allogeneic stem cell transplantation is now a major pillar in the treatment of multiple myeloma. CAR-T-cell technology monoclonal or bispecific antibodies as well as new forms of cellular therapy have revolutionized the treatment of this hematological malignancy.</p>